Please assess the completion status of the following clinical trial:

Trial Title: The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient ≥ 18years old~* Stable angina symptoms~* Elective treatment to coronary lesion~* Reference vessel diameters of ≥ 2.5mm and ≤ 4.0 mm on visual inspection~Exclusion Criteria:~* Left main stem lesion~* Bifurcation lesions~* Acute coronary syndrome (UAP, NSTEMI, STEMI)~* Cardiogenic shock~* Chronic total occlusion~* Additional lesions requiring PCI~* Platelet count ≤ 50 x 109/mm3~* Left ventricular ejection fraction ≤ 30%~* Patient life expectancy less than 12 months~* Known allergies to aspirin, clopidogrel, prasugrel, heparin, stainless steel, intravenous contrast (severe), or paclitaxel~* Participation in another investigational drug or device study~* Patient unable to give informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Stent (Type: ACTIVE_COMPARATOR): drug eluting stent (Resolute)
- drug eluting balloon (Type: EXPERIMENTAL): drug eluting balloon (Elutax)

Based on this trial design, predict the completion outcome and termination type (if applicable).